Rodrigo D. Michelli

Barretos, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.

Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.

Journal: Human mutation

Published: June 02, 2020

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer.

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer.

Journal: Genetics and molecular biology

Published: March 01, 2019

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Journal: Human mutation

Published: January 30, 2019

Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients.

Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: April 05, 2018

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.

Journal: Cancer medicine

Published: January 18, 2017

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.

Journal: Oncotarget

Published: April 04, 2016

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes.

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes.

Journal: Hereditary cancer in clinical practice

Published: June 24, 2015

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers.

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers.

Journal: Familial cancer

Published: January 08, 2015

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.

Journal: Genetics and molecular biology

Published: December 12, 2014

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.

Journal: PloS one

Published: December 31, 2013

The evolution of mastectomies in the oncoplastic breast surgery era.

The evolution of mastectomies in the oncoplastic breast surgery era.

Journal: Gland surgery

Published: April 12, 2013

A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Journal: Virchows Archiv : an international journal of pathology

Published: November 29, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026